Vision Screening for Older Drivers
Laws requiring vision screening for older are a plausible means of reducing crashes involving older drivers, but there is insufficient evidence to rigorously assess their effectiveness at this time.
Product Type:
Your search returned 786 results
Product
Product
Water Fluoridation
The Problem: Tooth decay, also known as dental caries, remains a major public health problem. Though largely preventable, it is the most common chronic disease for kids aged 6 to 11 years old and teens aged 12-19 years old. . CDC Dental Caries Fact Sheet. Advanced tooth decay can cause significant pain and loss of the teeth, and can be costly to treat. CDC: Oral Health: At a Glance: 2009.
Product Type:
Product
The Effects of Laws Authorizing Coercive Tuberculosis Control Measures
The Problem: Tuberculosis is a classic public health scourge. TB is one of the top 10 causes of death globally. World Health Organization: Tuberculosis Fact Sheet. The risks associated with TB have increased with the emergence of more virulent and drug-resistant strains of the disease. In the United States, the rate of TB incidence and associated mortality declined precipitously for most of the 20th century.
Product Type:
Product
“Shall Issue” Concealed Weapons Laws
The Problem: Firearms were a leading cause of death in the United States in 2017, accounting for 39,659deaths nationwide, with about 14,500 of those due to homicide CDC: Fast stats US Department of Justice: Crime Statistics.
Product Type:
Product
Enhanced Enforcement of Safety Belt Laws
The Problem: In 2018, the seatbelt usage rate in the U.S. was 89.6%. Seat belt usage saved an estimated 14,955 lives in 2017. National Highway Traffic Safety Administration (NHTSA) However, despite rising rates of safety belt use in the United States over the past 20 years, a lack of usage can lead to long-term chronic health consequences as well as death. David J. Houston and Lilliard E. Richardson, Jr.
Product Type:
Product
Alcohol, Drugs and Tobacco – Effects of Dram Shop Liability
The Problem: Alcohol consumption is a risk factor for many public health harms. Impaired driving is one of the largest contributors to motor vehicle crashes. Each year in the United States more than 10,000 people die in motor vehicle crashes involving an alcohol-impaired driver. In 2016, these crashes accounted for almost one-third of all U.S. traffic-related deaths. CDC: Impaired Driving Factsheet.
Product Type:
Product
Workplace Smoking Bans Reduce Acute Myocardial Infarction (AMI)
The Problem: Tobacco use is a source of chronic and fatal illnesses for users and persons with secondary exposure. Smoking is responsible for approximately 1 in 5 deaths in the United States, causing 480,000 deaths annually. Smoking increases risk for stroke by 2-4 times, coronary heart disease by 2-4 times, lung cancer by about 25 times, and lowers overall health. Quitting smoking vastly reduces risk; within 2-5 of cessation, risk of stroke drops to that of a non-smoker.
Product Type:
Product
Tobacco Use and Secondhand Smoke Exposure: Smoke-Free Policies
The Problem: Tobacco use is a source of chronic and fatal illnesses for users and people exposed to tobacco smoke. Second-hand smoke exposure contributes to 41,000 deaths among non-smoking adults, and 400 infants annually. Second-hand exposure can lead to stroke, lung cancer and coronary heart disease. Children exposed to second-hand smoke are at increased risk for slowed lung growth, asthma, acute respiratory infections, middle ear infections and sudden infant death syndrome.
Product Type:
Product
Medicaid Coverage of Medication Assisted Treatment
This dataset examines statutes, regulations, and preferred drug lists regarding Medicaid’s coverage of Medication Assisted Treatment (MAT). This dataset includes questions on which of the ten U.S. Food & Drug Administration (FDA) approved MAT drugs are covered by Medicaid.
This dataset is cross-sectional, capturing currently effective law valid through August 1, 2019.
Product Type:
Product
Medication Assisted Treatment in State Correctional Facilities
This preliminary dataset examines the laws and policies on medication assisted treatment (MAT) for opioid use disorder at state correctional facilities. The U.S. Food & Drug Administration (FDA) has approved three drugs for the treatment of opioid use disorder: buprenorphine, methadone, and naltrexone. Currently, Rhode Island is the only state that offers all three FDA-approved medications for MAT to all state inmates. Some states provide all three medications at some of their correctional facilities.
Product Type: